Kiniksa Pharmaceuticals International, plc

KNSA · Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

Kiniksa Pharmaceuticals International, plc (KNSA), in the Healthcare sector, has 27 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 0 purchases and 27 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Nov 4 and filed Nov 6. The most active filer was Mark Ragosa with 6 filings. Data as of Nov 7 2026.

Add to watchlist

Filings, ttm

0 buys · 27 sells

Traders, ttm

8 insiders

Volume, ttmiDollar value disclosed in the window

$120.2M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Nov 4

Filed yesterday

ADViAverage daily dollar volume

$60.8M

market data

Share price · 12M

$93.86 (+137.6%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $175.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months

Eben Tessari CHIEF OPERATING OFFICER 19 filings · 0 buys, 19 sales MR

Mark Ragosa CHIEF FINANCIAL OFFICER 14 filings · 0 buys, 14 sales MM

Michael R Megna CHIEF ACCOUNTING OFFICER 10 filings · 0 buys, 10 sales SP

Sanj K Patel CHAIRMAN & CEO 9 filings · 0 buys, 9 sales RM

Ross Moat CHIEF OPERATING OFFICER 7 filings · 0 buys, 7 sales BQ

Barry D Quart Director 6 filings · 0 buys, 6 sales JP

John F. Paolini CHIEF MEDICAL OFFICER 5 filings · 0 buys, 5 sales GC

G Bradley Cole Director 1 filing · 0 buys, 1 sale

All 9 filers

Thomas Malley Director 1 filing · 0 buys, 1 sale

Recent filings

Sanj K PatelSALE CHAIRMAN & CEO $14.3M
151,300 sh across 5 lots
Exec Nov 4
Filed Nov 6 · 4:52 PM ET Sanj K PatelSALE CHAIRMAN & CEO $37.4M
402,394 sh across 14 lots
Exec Oct 30
Filed Nov 3 · 7:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $3.4M
36,563 sh across 3 lots
Exec Nov 2
Filed Nov 3 · 6:32 PM ET John F. PaoliniSALE CHIEF MEDICAL OFFICER $8.8M
94,397 sh across 8 lots
Exec Oct 30
Filed Nov 3 · 6:28 PM ET Ross MoatSALE CHIEF OPERATING OFFICER $9.6M
102,863 sh across 10 lots
Exec Oct 30
Filed Nov 3 · 6:27 PM ET Michael R MegnaSALE CHIEF ACCOUNTING OFFICER $3.4M
36,260 sh across 7 lots
Exec Oct 30
Filed Nov 3 · 6:26 PM ET Michael R MegnaSALE CHIEF ACCOUNTING OFFICER $369K
4,600 sh × $80.30
Exec Sep 3
Filed Sep 3 · 4:40 PM ET G Bradley ColeSALE Director $299K
3,673 sh × $81.43
Exec Jul 29
Filed Jul 31 · 4:34 PM ET John F. PaoliniSALE CHIEF MEDICAL OFFICER $3.1M
58,424 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET Sanj K PatelSALE CHAIRMAN & CEO $2.6M
48,565 sh × $54.02
Exec May 1
Filed May 1 · 5:30 PM ET Sanj K PatelSALE CHAIRMAN & CEO $26.4M
508,339 sh across 6 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET Barry D QuartSALE Director $656K
13,099 sh × $50.10
Exec Apr 28
Filed Apr 29 · 5:30 PM ET Michael R MegnaSALE CHIEF ACCOUNTING OFFICER $309K
6,625 sh × $46.69
Exec Apr 9
Filed Apr 13 · 5:30 PM ET Barry D QuartSALE Director $345K
6,901 sh × $50.00
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Ross MoatSALE CHIEF OPERATING OFFICER $115K
2,367 sh × $48.58
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Sanj K PatelSALE CHAIRMAN & CEO $364K
7,278 sh × $50.01
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $1.7M
36,722 sh across 2 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET John F. PaoliniSALE CHIEF MEDICAL OFFICER $1.8M
40,000 sh across 3 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Barry D QuartSALE Director $121K
2,690 sh × $45.00
Exec Feb 12
Filed Feb 12 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $772K
17,845 sh across 2 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET Barry D QuartSALE Director $684K
15,130 sh across 2 lots
Exec Feb 3
Filed Feb 4 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $503K
12,000 sh × $41.89
Exec Jan 8
Filed Jan 9 · 5:30 PM ET Eben TessariSALE CHIEF OPERATING OFFICER $501K
12,048 sh × $41.56
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET Barry D QuartSALE Director $836K
20,129 sh × $41.51
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $1.8M
42,841 sh × $41.49
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET